Close this search box.


health 2.0 Conference

3rd - 5th December 2024, Rethinking The Healthcare Landscape
Read more

Precision Med Exhibition & Summit

18th - 19thSeptember 2024, Knowledge and clinical application in precision medicine
Read more

MedTech Malta

6th - 8th September 2024, MedTech Innovation
Read more

12. German Biobank Node 2024

23th - 24th September 2024, Meeting of the Biobank-Community
Read more

Deutscher Kongress für Laboratoriumsmedizin 2024

26th - 2thSeptember 2024, DGKL
Read more

Big Bang KI Festival

11th - 12th September 2024, Germany's pioneer for artificial intelligence in the SME sector
Read more

Recommended for you

Read the Cover Story at the MedEdge, May – June 2024, Page 6 form our CEO Dr. Ali Tinazli

Press and Media

Meet us: at the upcoming events

We would love to meet you in person!


Our interdisciplinary team of dedicated scientists can boast of various technical publications. In addition, several publications are in the pipeline. If you need further information, please do not hesitate to contact us.

Brandsma et al.: Metabolic Profiling of COVID-19 and Influenza-like Illness in a Multi-Centre Adaptive Platform Trial of Respiratory Infections Poster, Keystone Symposia on Molecular and Cellular Biology in Colorado (2024).

Ladurner M., Ameismeier T., Klocker H., Steiner E., Hauffe H., Wittmann J., Drettwan D., Eder I: NMR-based metabolomics discriminate between prostate biopsy-positive and biopsy-negative patients suspicious for prostate cancer. Poster, European Association of Urology, Paris (2024).

Erik Fung, Eunice Y. S. Chan, Kwan Hung Ng1, Ka Man Yu1, Huijun Li and Yulan Wang:
Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates.
Journal of Inflamation 20, Article number: 32 (2023).

Ladurner M., Ameismeier T., Klicker H., Steiner E., Hauffe H., Wittmann J., Drettwan D. Eder I.: NMR-based metabolimics discriminates between biopsy-negative patients with elevated PSA.
Poster, SBUR, San Antonio (2023).

Wahl, L.; Raschke, M.; Wittmann, J.; Regler, A.; Heelemann, S.; Brandsch, C.; Stangl, G.I.; Vervuert, I.:
Effects of atherogenic diet supplemented with fermentable carbohydrates on metabolic responses and plaque formation in coronary arteries using a Saddleback pig model.
PLOS ONE. 17(10):e0275214. (2022)

Wilmer, L., Tränkner, M., Pawelzik, E. & Naumann, M.:
Sufficient potassium supply enhances tolerance of potato plants to PEG-induced osmotic stress.
Plant Stress 5, 100102 (2022).

Kanski, L.; Kahle, H.; Naumann, M.; Hagenguth, J.; Ulbrich, A.; Pawelzik, E.:
Cultivation Systems, Light Intensity, and Their Influence on Yield and Fruit Quality Parameters of Tomatoes.
Agronomy. 11, 1203. (2021)

Chea, L.; Pfeiffer, B.; Schneider, D.; Daniel, R.; Pawelzik, E.; Naumann, M.:
Morphological and Metabolite Responses of Potatoes under Various Phosphorus Levels and Their Amelioration by Plant Growth‐Promoting Rhizobacteria.
International Journal of Molecular Sciences. 22, 5162. (2021)

Westermeier, P.; Albrecht, T.; Geyer, R.; Willner, E. and Hartmann, S.:
Analysis of drought tolerance in perennial ryegrass (Lolium perenne L.) with methods of genomic prediction.
Grassland Sci Europe, 24, 421-423. (2019)

Geyer, R.; Eickmeyer, F.; Rettig, M.; Heelemann, S.; Kirchhöfer, R.:
Bedeutung einer effizienten Charakterisierung pflanzlicher Extrakte für die Züchtung und den Übergang von der Wildsammlung zum kontrollierten Anbau.
Julius-Kühn-Archiv. 460, 72-75. (2018)


We are honored to have been selected as one of the finalists for the 5-HT Digital Health for Pharma program. We are excited to share our perspectives of digital solutions for pharma at the 5-HT Digital Hub – Chemistry & Health event on April 8th 2022.

Press releases

Do you need approved texts and images for reports or press releases? Please contact our marketing department.
Scroll to Top

Dr. Roland Geyer

10+ years experience in NMR-based metabolomics and diagnostic.

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.

Dr. Ali Tinazli

CEO, lifespin GmbH

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).